Literature DB >> 19886969

Optimizing left-sided live kidney donation: hand-assisted retroperitoneoscopic as alternative to standard laparoscopic donor nephrectomy.

Leonienke F C Dols1, Niels F M Kok, Turkan Terkivatan, Khe T C Tran, Ian P J Alwayn, Willem Weimar, Jan N M Ijzermans.   

Abstract

Laparoscopic donor nephrectomy (LDN) is less traumatic and painful than the open approach, with shorter convalescence time. Hand-assisted retroperitoneoscopic (HARP) donor nephrectomy may have benefits, particularly in left-sided nephrectomy, including shorter operation and warm-ischemia time (WIT) and improved safety. We evaluated outcomes of HARP alongside LDN. From July 2006 to May 2008, 20 left-sided HARP procedures and 40 left-sided LDNs were performed. Intra and postoperative data were prospectively collected and analysis on outcome of both techniques was performed. More female patients underwent HARP compared to LDN (75% vs. 40%, P = 0.017). Other baseline characteristics were not significantly different. Median operation time and WIT were shorter in HARP (180 vs. 225 min, P = 0.002 and 3 vs. 5 min, P = 0.007 respectively). Blood loss did not differ (200 ml vs.150 ml, P = 0.39). Intra and postoperative complication rates for HARP and LDN (respectively 10% vs. 25%, P = 0.17 and 5% vs. 15%, P = 0.25) were not significantly different. During median follow-up of 18 months estimated glomerular filtration rates in donors and recipients and graft- and recipient survival did not differ between groups. Hand-assisted retroperitoneoscopic donor nephrectomy reduces operation and warm ischemia times, and provides at least equal safety. Hand-assisted retroperitoneoscopic may be a valuable alternative for left-sided LDN.

Entities:  

Mesh:

Year:  2009        PMID: 19886969     DOI: 10.1111/j.1432-2277.2009.00990.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  6 in total

1.  Optimizing a living kidney donation program: transition to hand-assisted retroperitoneoscopic living donor nephrectomy and introduction of a passive polarizing three-dimensional display system.

Authors:  Roger Wahba; Robert Kleinert; Martin Hellmich; Nadine Heiermann; Georg Dieplinger; Hans A Schlößer; Denise Buchner; Christine Kurschat; Dirk L Stippel
Journal:  Surg Endosc       Date:  2016-10-04       Impact factor: 4.584

2.  Hand-assisted retroperitoneoscopic versus standard laparoscopic donor nephrectomy: HARP-trial.

Authors:  Leonienke F C Dols; Niels F M Kok; Turkan Terkivatan; T C Khe Tran; Frank C H d'Ancona; Johan F Langenhuijsen; Ingrid R A M zur Borg; Ian P J Alwayn; Mark P Hendriks; Ine M Dooper; Willem Weimar; Jan N M Ijzermans
Journal:  BMC Surg       Date:  2010-03-25       Impact factor: 2.102

3.  Renal Function Recovery in Donors and Recipients after Live Donor Nephrectomy: Hand-Assisted Laparoscopic vs. Open Procedures.

Authors:  Bum Soo Kim; Eun Sang Yoo; Tae-Hwan Kim; Tae Gyun Kwon
Journal:  Korean J Urol       Date:  2010-04-20

4.  The Learning Curve of Pure Retroperitoneoscopic Donor Nephrectomy.

Authors:  B C Pal; P R Modi; S J Rizvi; R Chauhan; S Kumar; R Nagarajan; D Kaushal; V B Kute; H L Trivedi
Journal:  Int J Organ Transplant Med       Date:  2017-11-01

5.  Deep neuromuscular block reduces the incidence of intra-operative complications during laparoscopic donor nephrectomy: a pooled analysis of randomized controlled trials.

Authors:  Gabby T J A Reijnders-Boerboom; Esmee V van Helden; Robert C Minnee; Kim I Albers; Moira H D Bruintjes; Albert Dahan; Chris H Martini; Frank C H d'Ancona; Gert-Jan Scheffer; Christiaan Keijzer; Michiel C Warlé
Journal:  Perioper Med (Lond)       Date:  2021-12-09

6.  Comparison of the effectiveness of low pressure pneumoperitoneum with profound muscle relaxation during laparoscopic donor nephrectomy to optimize the quality of recovery during the early post-operative phase: study protocol for a randomized controlled clinical trial.

Authors:  Denise M D Özdemir-van Brunschot; Gert J Scheffer; Albert Dahan; Janneke E E A Mulder; Simone A A Willems; Luuk B Hilbrands; Frank C H d'Ancona; Rogier A R T Donders; Kees J H M van Laarhoven; Michiel C Warlé
Journal:  Trials       Date:  2015-08-12       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.